LUNG: Pulmonx Company Sales Revenue

Corporate emblem and logo of Pulmonx (LUNG)

Pulmonx Corporation (LUNG) has achieved a breakthrough by developing minimally invasive systems for the treatment of severe emphysema. Reviewing the company's sales performance on GURU.Markets, it is evident how the value of 0.09 describes the current revenue level. Growth is driven by strong pricing power within pulmonology, while Zephyr's status as a medical standard and its insurance coverage create a powerful defensive moat for the business.

Revenue and Sales Volume: Pulmonx Corp (LUNG) for 07/04/2022 - 11/17/2026

Comprehensive metric breakdowns and analytics for Pulmonx (LUNG)

- stock value and consensus price forecast:
- market capitalization information:
Summary company analysis:LUNG Pulmonx
Product sample of pulmonx.com

The deployment of robotic lines and AI modules at Pulmonx Corporation (LUNG) directly scales the commercial potential of its medical valves. This metric aggregates total cash inflows from core operations, measuring real market demand for high-tech products. Revenue dynamics determine the issuer's financial stability and allow for the timely detection of cash flow stagnation. Analyzing the company's sales volume helps investors accurately identify entry points, avoiding the purchase of the asset at its peak.

Key competitors

Company Sales Dexcom (DXCM)|Company Revenue Penumbra Inc (PEN)|NOVT (Novanta Inc) - Company Sales Revenue|Revenue and Sales Volume HAE (haemonetics.com)|INSP - Company Sales|PROCEPT BioRobotics Corp - Revenue and Sales Volume|Company Total Revenue CONMED Corporation|PLSE: Revenue and Sales Volume|Company Sales Volume INMD|PMI (Picard Group) - Revenue and Sales Volume|Surmodics Corp (SRDX) - Company Gross Revenue|Revenue and Sales Volume SENS|Company Sales NeuroPace, Inc. NPCE|Revenue and Sales Volume TCMD (Tactile Systems Technology, Inc.)|Revenue and Sales Volume SANUWAVE Health SNWV|outsetmedical.com - Revenue and Sales Volume|ELMD: Company Revenue|LNSR (LENSAR, Inc.) - Company Sales|AVITA Medical, Inc. - Company Sales Revenue|PROF (Profound Medical Corp) - Revenue and Sales Volume|Company Total Revenue bairdmed.com BDMD|Company Revenue EDAP TMS (EDAP)|Bovie Medical (APYX) - Company Total Sales Volume|IceCure Medical Ltd. - Company Sales|Revenue and Sales Volume TELA Bio Corp TELA|CytoSorbents Corp - Revenue and Sales Volume|Company Gross Revenue Sensus Healthcare Inc SRTS|Zynex (ZYXI) - Company Revenue|Company Annual Revenue ECOR (electroCore Medical)|Company Revenue vicarioussurgical.com|Company Sales Inspira Technologies Oxy (IINN)|Company Revenue SeaStar Medical Holding Corp (ICU)|IRIX - Company Total Revenue|Company Revenue ibs.inc INBS|XAIR: Company Sales Volume|PFSA: Company Sales|STRATA Skin Sciences, Inc. - Company Total Sales|GCTK: Revenue and Sales Volume|Company Sales Volume NAOV|VERO (venusconcept.com) - Revenue and Sales Volume|Revenue and Sales Volume Nuwellis, Inc.|Company Sales AEMD (Aethlon)|ASXC - Company Total Revenue|Company Revenue Avinger, Inc AVGR|Company Gross Revenue BioSig Technologies Inc. (BSGM)|CUTR - Company Revenue|KNW: Company Revenue|NARI (Inari Medical, Inc.) - Company Sales|Nevro Corp. - Company Sales Revenue|RSLS (ReShape Lifesciences, Inc.) - Revenue and Sales Volume|Company Total Revenue Silk Road Medical SILK